Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Beximco Pharmaceuticals Limited, often referred to as Beximco Pharma, is a leading player in the pharmaceutical industry, headquartered in Dhaka, Bangladesh (BD). Established in 1976, the company has made significant strides in the production of high-quality generic medicines, active pharmaceutical ingredients (APIs), and over-the-counter products, catering to both domestic and international markets.
With a strong focus on research and development, Beximco Pharma has developed a diverse portfolio that includes formulations across various therapeutic areas, such as cardiology, oncology, and anti-infectives. The company is renowned for its commitment to quality and innovation, which has positioned it as a trusted name in the global pharmaceutical landscape. Notable achievements include regulatory approvals from prestigious agencies, underscoring its reputation for excellence and reliability in healthcare solutions.
-22 vs industry average
Beximco Pharmaceuticals Limited’s score of 20 is lower than 12% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Beximco Pharmaceuticals Limited yet.
Beximco Pharmaceuticals Limited, headquartered in Bangladesh (BD), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges available from the company.
As of now, Beximco Pharmaceuticals Limited has not inherited any emissions data from a parent or related organization, nor does it have any commitments to science-based targets (SBTi) or other climate initiatives. This lack of data suggests that the company may still be in the early stages of developing its climate strategy and emissions reporting framework.
In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction initiatives. Beximco Pharmaceuticals Limited may benefit from aligning with industry standards and setting measurable targets to enhance its environmental performance in the future.
No climate goals have been disclosed for Beximco Pharmaceuticals Limited yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more